This inventor holds 1 USPTO granted patent. Top assignee: Dna Vec Research Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations of Hidekazu Kuma in Gene Therapy
Introduction
Hidekazu Kuma is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of gene therapy through his innovative work on Paramyxovirus vectors. His research focuses on developing viral vectors that can be utilized in therapeutic applications.
Latest Patents
Kuma holds a patent for an "Envelope gene-deficient Paramyxovirus vector." This invention involves the successful recovery of F gene-deficient virus virions using an F gene-deficient Sendai virus genomic cDNA. Additionally, he has constructed F gene-deficient infectious viral particles by employing F-expressing cells as helper cells. His work also includes recovering F gene and HN gene-deficient virus virions and producing infectious viral particles using F- and HN-expressing cells. Furthermore, he has constructed a virus deficient in both F gene and HN gene, utilizing F-expressing cells as helper cells. His techniques contribute significantly to the development of Paramyxoviridae vectors for gene therapy applications.
Career Highlights
Kuma is associated with Dna Vec Research Inc., where he continues to advance his research in viral vectors. His innovative approaches have positioned him as a key figure in the field of gene therapy.
Collaborations
Kuma has collaborated with notable colleagues, including Kaio Kitazato and Tsugumine Shu. Their combined expertise enhances the research and development of gene therapy techniques.
Conclusion
Hidekazu Kuma's contributions to the field of gene therapy through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in therapeutic applications using viral vectors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile